Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-11, Stock:JNJ, The news for the past five days is as follows:
2018-07-03: NEWS1: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS2: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS3: Stocks Erase Early Gains Ahead of July Fourth Holiday.NEWS4: Stocks Erase Early Gains Ahead of July Fourth Holiday.NEWS5: How to Invest in Pharmaceutical Stocks: A Beginner&apos;s Guide.NEWS6: Market Close Report: NASDAQ Composite index closes at 7,502.67 down -65.02 points.NEWS7: Market Close Report: NASDAQ Composite index closes at 7,502.67 down -65.02 points.NEWS8: Stocks Drift Lower; Micron Slumps On China Ruling; Royal Gold Breaks Out.NEWS9: Fortive Set to Buy Gordian, Expands Field Solutions Portfolio.NEWS10: Fortive Set to Buy Gordian, Expands Field Solutions Portfolio.NEWS11: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 05, 2018.NEWS12: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 05, 2018.NEWS13: Your first trade for July 3, 2018.NEWS14: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS15: Remember When Was The Last Time A New Alzheimer's Drug Was Approved?.NEWS16: Remember When Was The Last Time A New Alzheimer's Drug Was Approved?.
2018-07-05: NEWS1: Some Recent Pharmaceutical Mergers and Acquisitions.NEWS2: Fed minutes warn of rising trade risks.NEWS3: Everett-based Fortive Corp. is eager to deploy its $4B M&A war chest.NEWS4: Kiplinger Dividend 15: CVS Interrupts Its String of Hikes.NEWS5: Here's Why AbbVie Stock is Good for Your Portfolio's Health.NEWS6: Here's Why AbbVie Stock is Good for Your Portfolio's Health.NEWS7: JNK, HCRF: Big ETF Outflows.NEWS8: JNK, HCRF: Big ETF Outflows.NEWS9: Pfizer's Stock Ready for a 10% Rebound.NEWS10: An Update on JNJ’s Neuroscience Business after Q1 2018.NEWS11: Merck & Co.: Wall Street Analysts Are Mostly Positive in July.NEWS12: JNJ’s Infectious Diseases Segment Witnessed ~11% YoY Growth.NEWS13: An Update on Johnson & Johnson’s Immunology Business.
2018-07-06: NEWS1: What the Second Half of 2018 Has in Store for Investors.NEWS2: What the Second Half of 2018 Has in Store for Investors.NEWS3: Why Geron Corp. Stock Has Skyrocketed 90.6% in 2018 (So Far).NEWS4: Why Geron Corp. Stock Has Skyrocketed 90.6% in 2018 (So Far).NEWS5: Why Geron Corp. Stock Has Skyrocketed 90.6% in 2018 (So Far).NEWS6: What the Second Half of 2018 Has in Store for Investors.NEWS7: Trade of the Day: Novocure Ltd (NVCR).NEWS8: Trade of the Day: Novocure Ltd (NVCR).NEWS9: Kiplinger Dividend 15: CVS Interrupts Its String of Hikes.NEWS10: Kiplinger Dividend 15: CVS Interrupts Its String of Hikes.NEWS11: Biogen's Alzheimer Disease Candidate Succeeds in Phase II.NEWS12: Biogen's Alzheimer Disease Candidate Succeeds in Phase II.NEWS13: Don’t Buy Biogen Stock on the Promise of an Alzheimer’s Breakthrough.NEWS14: IWB, JPM, JNJ, BAC: Large Outflows Detected at ETF.NEWS15: IWB, JPM, JNJ, BAC: Large Outflows Detected at ETF.NEWS16: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.NEWS17: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.NEWS18: Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs.NEWS19: Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs.NEWS20: JNJ’s CAR T Cell Therapy and Erdafitinib: Growth Drivers.NEWS21: Biogen&apos;s Alzheimer Disease Candidate Succeeds in Phase II.NEWS22: 3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July.NEWS23: Trade of the Day: Novocure Ltd (NVCR).NEWS24: JNJ’s Oncology Business Witnessed 45% Growth in Q1 2018.NEWS25: Free Pre-Market Technical Recap on Sanofi and Three Additional Drug Makers Stocks.NEWS26: Darzalex Could Boost JNJ’s Revenue Growth in 2018.
2018-07-09: NEWS1: JNJ Partners with Mercy for Real-World Data Insights for Research.NEWS2: Johnson & Johnson’s Medical Devices Business.NEWS3: Johnson & Johnson’s Erleada Approved by Health Canada.NEWS4: Johnson & Johnson Stock Only Benefits from Big Moves That May Not Come.NEWS5: The Performance of Johnson & Johnson’s Cardiovascular Segment.NEWS6: Why RBC Capital Markets Lowered Its Target Price on JNJ Stock.NEWS7: Johnson & Johnson’s Pulmonary Hypertension Business.
2018-07-10: NEWS1: Dow ETF in Focus Ahead of Q2 Earnings.NEWS2: Dow ETF in Focus Ahead of Q2 Earnings.NEWS3: See Which Of The Latest 13F Filers Holds Johnson & Johnson.NEWS4: See Which Of The Latest 13F Filers Holds Johnson & Johnson.NEWS5: JNJ’s Vision Care Segment Witnessed Solid Growth in Q1 2018.NEWS6: A Performance Overview of JNJ’s Surgical Medical Devices Business.NEWS7: How Is Johnson & Johnson’s Orthopedics Business Positioned?.

Answer: Decrease